• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响抗逆转录病毒治疗患者卡波西肉瘤相关疱疹病毒潜伏和裂解抗原抗体反应的危险因素。

Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.

机构信息

Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.

出版信息

J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):83-90. doi: 10.1097/QAI.0b013e3181fdc928.

DOI:10.1097/QAI.0b013e3181fdc928
PMID:21084997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3051282/
Abstract

BACKGROUND

Kaposi's sarcoma-associated herpesvirus (KSHV) seropositivity and lytic antibody titer are predictors for Kaposi's sarcoma.

METHODS

We examined demographic, viral, and immunologic factors that influence KSHV latent and lytic antibodies in HIV-infected patients.

RESULTS

Detection rate of KSHV latent but not lytic antibodies was lower in patients with CD4 cells/mm3 less than 200 than greater than 200 (odds ratio [OR], 0.26; 95% confidence interval [CI], 0.11-0.61) and CD8 cells/mm3 less than 400 than greater than 400 (OR, 0.26; 95% CI, 0.07-0.67). Overall seropositivity rate was higher in patients with CD4 cells/mm3 less than 200 than greater than 200 (OR, 2.34; 95% CI, 1.37-4.02) and HIV copies/mL greater than 400 than less than 400 (OR, 1.70; 95% CI, 1.09-2.65). Lytic antibody level was inversely correlated with CD4 count (P < 0.001). Lytic seropositivity (OR, 2.47; 95% CI, 1.35-4.50) and antibody level (adjusted difference mean optical density, 0.324; 95% CI, 0.16-0.46) were higher in patients with HIV infection greater than 15 than less than 15 years. Hispanics had higher lytic seropositivity rate (OR, 1.71; 95% CI, 1.07-2.73) and antibody level (adjusted difference mean optical density, 0.111; 95% CI, 0.03-0.18) than non-Hispanics.

CONCLUSIONS

Lower CD4 and CD8 counts impair antibody response to KSHV latent antigens. Immune deterioration, long-term HIV infection, and Hispanic status are risk factors for Kaposi's sarcoma predictors.

摘要

背景

卡波西肉瘤相关疱疹病毒(KSHV)血清阳性和裂解抗体滴度是卡波西肉瘤的预测因子。

方法

我们研究了影响 HIV 感染者 KSHV 潜伏和裂解抗体的人口统计学、病毒学和免疫学因素。

结果

与 CD4 细胞/mm3 大于 200 的患者相比,CD4 细胞/mm3 小于 200 的患者潜伏抗体的检出率较低,而裂解抗体的检出率则无差异(比值比[OR],0.26;95%置信区间[CI],0.11-0.61);与 CD8 细胞/mm3 大于 400 的患者相比,CD8 细胞/mm3 小于 400 的患者潜伏抗体的检出率较低,而裂解抗体的检出率则无差异(OR,0.26;95% CI,0.07-0.67)。与 CD4 细胞/mm3 大于 200 的患者相比,CD4 细胞/mm3 小于 200 的患者总血清阳性率较高(OR,2.34;95% CI,1.37-4.02),HIV 拷贝数/mL 大于 400 的患者比 HIV 拷贝数/mL 小于 400 的患者较高(OR,1.70;95% CI,1.09-2.65)。裂解抗体水平与 CD4 计数呈负相关(P < 0.001)。与 HIV 感染小于 15 年的患者相比,HIV 感染大于 15 年的患者的裂解血清阳性率(OR,2.47;95% CI,1.35-4.50)和抗体水平(调整后平均光密度差异,0.324;95% CI,0.16-0.46)较高。与非西班牙裔患者相比,西班牙裔患者的裂解血清阳性率(OR,1.71;95% CI,1.07-2.73)和抗体水平(调整后平均光密度差异,0.111;95% CI,0.03-0.18)较高。

结论

较低的 CD4 和 CD8 计数会损害针对 KSHV 潜伏抗原的抗体反应。免疫恶化、长期 HIV 感染和西班牙裔身份是卡波西肉瘤预测因子的危险因素。

相似文献

1
Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.影响抗逆转录病毒治疗患者卡波西肉瘤相关疱疹病毒潜伏和裂解抗原抗体反应的危险因素。
J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):83-90. doi: 10.1097/QAI.0b013e3181fdc928.
2
Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.艾滋病相关卡波西肉瘤患者对卡波西肉瘤相关疱疹病毒(人疱疹病毒8型)潜伏核抗原的血清反应性取决于CD4+T细胞计数。
J Med Virol. 2007 Oct;79(10):1562-8. doi: 10.1002/jmv.20949.
3
A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.一项针对感染人类免疫缺陷病毒1型的成人患者中卡波西肉瘤相关疱疹病毒和爱泼斯坦-巴尔病毒的前瞻性研究。
Br J Cancer. 2006 May 22;94(10):1504-9. doi: 10.1038/sj.bjc.6603100.
4
Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.在瑞士艾滋病毒队列研究中,高效抗逆转录病毒治疗后卡波西肉瘤疱疹病毒抗体反应和病毒血症。
AIDS. 2010 Sep 10;24(14):2245-52. doi: 10.1097/QAD.0b013e32833b7830.
5
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.卡波西肉瘤相关疱疹病毒特异性免疫重建以及高效抗逆转录病毒治疗/化疗联合方案对感染C型HIV且患有卡波西肉瘤个体的抗病毒作用
AIDS. 2007 Jun 19;21(10):1245-52. doi: 10.1097/QAD.0b013e328182df03.
6
Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.人类免疫缺陷病毒(HIV)感染期间发生的人类疱疹病毒8型血清转化对卡波西肉瘤具有高度预测性。
AIDS. 1998 Dec 24;12(18):2481-8. doi: 10.1097/00002030-199818000-00018.
7
Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy.卡波西肉瘤相关疱疹病毒(KSHV)特异性细胞毒性T淋巴细胞表位的鉴定以及接受高效抗逆转录病毒治疗的1型人类免疫缺陷病毒感染患者中KSHV特异性反应重建的评估。
J Virol. 2002 Mar;76(6):2634-40. doi: 10.1128/jvi.76.6.2634-2640.2002.
8
Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.检测和定量卡波西肉瘤相关疱疹病毒以预测艾滋病相关卡波西肉瘤。
AIDS. 2003 Aug 15;17(12):1847-51. doi: 10.1097/00002030-200308150-00015.
9
Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.人类免疫缺陷病毒感染的卡波西肉瘤患者外周血中人类疱疹病毒8的病毒载量
J Clin Microbiol. 2001 Dec;39(12):4269-73. doi: 10.1128/JCM.39.12.4269-4273.2001.
10
Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.儿童原发性感染卡波西肉瘤相关疱疹病毒后体液免疫应答的纵向分析。
J Med Virol. 2016 Nov;88(11):1973-81. doi: 10.1002/jmv.24546. Epub 2016 May 11.

引用本文的文献

1
Activation of glucocorticoid receptor signaling inhibits KSHV-induced inflammation and tumorigenesis.糖皮质激素受体信号的激活抑制 KSHV 诱导的炎症和肿瘤发生。
mBio. 2024 Jan 16;15(1):e0301123. doi: 10.1128/mbio.03011-23. Epub 2023 Dec 20.
2
Nitric oxide is induced and required for efficient Kaposi's sarcoma-associated herpesvirus lytic replication.一氧化氮诱导并需要有效的卡波西肉瘤相关疱疹病毒裂解复制。
J Med Virol. 2021 Nov;93(11):6323-6332. doi: 10.1002/jmv.27228. Epub 2021 Jul 29.
3
Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA.口腔卡波西肉瘤和细胞相关 KSHV DNA 感染者口腔微生物组特征。
PLoS Pathog. 2020 Jan 17;16(1):e1008114. doi: 10.1371/journal.ppat.1008114. eCollection 2020 Jan.
4
Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.喀麦隆西北部和西南部地区接受治疗和未接受治疗的 HIV-1 感染患者的遗传多样性和抗逆转录病毒耐药相关突变特征。
PLoS One. 2019 Nov 21;14(11):e0225575. doi: 10.1371/journal.pone.0225575. eCollection 2019.
5
FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.FoxO1 抑制卡波氏肉瘤相关疱疹病毒裂解复制并控制病毒潜伏。
J Virol. 2019 Jan 17;93(3). doi: 10.1128/JVI.01681-18. Print 2019 Feb 1.
6
TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway.Toll样受体4介导的炎症通过激活信号转导和转录激活因子3信号通路促进卡波西肉瘤相关疱疹病毒诱导的细胞转化和肿瘤发生。
Cancer Res. 2017 Dec 15;77(24):7094-7108. doi: 10.1158/0008-5472.CAN-17-2321. Epub 2017 Oct 19.
7
Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China.中国新疆维吾尔族 HIV 感染者中卡波西肉瘤相关疱疹病毒的血清流行率。
J Med Virol. 2017 Sep;89(9):1629-1635. doi: 10.1002/jmv.24804. Epub 2017 Apr 11.
8
Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi's Sarcoma-Associated Herpesvirus.用于检测卡波西肉瘤相关疱疹病毒抗体的快速多重免疫测定法。
PLoS One. 2016 Sep 26;11(9):e0163616. doi: 10.1371/journal.pone.0163616. eCollection 2016.
9
High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.在非流行地区的 HIV-1 感染儿童和青少年中,针对卡波济肉瘤相关疱疹病毒(KSHV)的抗体具有高血清阳性率。
Med Microbiol Immunol. 2016 Oct;205(5):425-34. doi: 10.1007/s00430-016-0458-x. Epub 2016 May 30.
10
Kaposi's sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania.卡波西肉瘤:坦桑尼亚一家三级护理医院对248例患者的10年经验。
BMC Res Notes. 2015 Sep 15;8:440. doi: 10.1186/s13104-015-1348-9.

本文引用的文献

1
Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China.中国新疆卡波西肉瘤相关疱疹病毒血清流行率及危险因素
J Med Virol. 2009 Aug;81(8):1422-31. doi: 10.1002/jmv.21550.
2
AIDS-related Kaposi's sarcoma in a patient with a normal CD4 count.一名CD4计数正常的患者患艾滋病相关卡波西肉瘤。
Clin Oncol (R Coll Radiol). 2008 Feb;20(1):97. doi: 10.1016/j.clon.2007.09.004. Epub 2007 Oct 22.
3
HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load.CD4计数高且病毒载量低的与HIV相关的卡波西肉瘤。
N Engl J Med. 2007 Sep 27;357(13):1352-3. doi: 10.1056/NEJMc070508.
4
Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.艾滋病相关卡波西肉瘤患者对卡波西肉瘤相关疱疹病毒(人疱疹病毒8型)潜伏核抗原的血清反应性取决于CD4+T细胞计数。
J Med Virol. 2007 Oct;79(10):1562-8. doi: 10.1002/jmv.20949.
5
Molecular biology of KSHV in relation to AIDS-associated oncogenesis.与艾滋病相关肿瘤发生相关的卡波西肉瘤相关疱疹病毒分子生物学
Cancer Treat Res. 2007;133:69-127. doi: 10.1007/978-0-387-46816-7_3.
6
Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.使用多抗原检测算法诊断卡波西肉瘤相关疱疹病毒感染。
J Clin Microbiol. 2006 Oct;44(10):3734-41. doi: 10.1128/JCM.00191-06.
7
Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.血浆HIV RNA水平对未经治疗的HIV感染中CD4 T细胞下降速率的预测价值。
JAMA. 2006 Sep 27;296(12):1498-506. doi: 10.1001/jama.296.12.1498.
8
Trends in cancer risk among people with AIDS in the United States 1980-2002.1980 - 2002年美国艾滋病患者的癌症风险趋势
AIDS. 2006 Aug 1;20(12):1645-54. doi: 10.1097/01.aids.0000238411.75324.59.
9
A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.一项针对感染人类免疫缺陷病毒1型的成人患者中卡波西肉瘤相关疱疹病毒和爱泼斯坦-巴尔病毒的前瞻性研究。
Br J Cancer. 2006 May 22;94(10):1504-9. doi: 10.1038/sj.bjc.6603100.
10
Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.高效抗逆转录病毒治疗期间艾滋病相关卡波西肉瘤的长期临床结局
Int J Oncol. 2005 Sep;27(3):779-85.